Clinical Updates

Johns Hopkins scientists have found that a safe and inexpensive antibiotic in use since the 1970s for treating acne effectively… »   

Drugs for eczema made by Novartis AG and Astellas Pharma may need their warning labels expanded after dozens of… »   

U.S. health regulators are taking a closer look at how well devices used by diabetics to monitor their blood sugars… »   

As much as $75 million in popular Eli Lilly & Co prescription medicines such as Prozac were stolen during a… »   

Anti-obesity drugs fall short of providing long lasting health benefits, researchers have pointed out.

Experts at the University of Liverpool… »   

The addition of the Novartis blood pressure medicine Tekturna to current standard drugs in patients who had a heart attack… »   

The potential riches for makers of obesity and diabetes treatments are irresistible to biotech entrepreneurs and investors. Rhythm Pharmaceuticals, a… »   

The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in… »   

People who take certain drugs for depression known as selective serotonin reuptake inhibitors (SSRIs) may have a higher-than-average risk of… »   

Even within the U.S. Veterans Affairs health system, where everyone should have the same access to care, African Americans are… »   

The blockbuster anti-clotting drug Plavix will carry a new warning about patients who have a poor response to the drug… »   

Poor people in India and other developing countries may lose access to affordable generic drugs as part of free-trade… »   

Vaccines that contain a mercury-based preservative called thimerosal cannot cause autism on their own, a special U.S. court ruled on… »   

Merck & Co on Thursday said an independent data safety monitoring board has approved continuation of a big study meant… »   

People whose “bad” cholesterol and risk of future heart disease stay too high despite cholesterol-lowering statin therapy can safely lower… »